Sort
15,273 grants matching “antimicrobial resistance”
Copper Chelating Compounds as Novel Antimicrobial Class
$40,341Sanjay Vijay Menghani · University Of Arizona · F30 · FY2021 · GM
Development of Selective Oxidative Biocatalytic Methods
$40,290Sarah Elizabeth Champagne · University Of Michigan At Ann Arbor · F31 · FY2023 · GM
Intracellular Calprotectin in the Cell-Autonomous Defense of the Oral Mucosa
$40,269Brent S Sorenson · University Of Minnesota · F30 · FY2009 · DE
Laboratory Capacity FDA CVM Vet-LIRN Veterinary Diagnostic Laboratory Program
$40,248Dubraska V Diaz-Campos · Ohio State University · U18 · FY2023 · FD
NRSA in Support of Meg Nas: Discovering the Novel Type IV Secretion System of Stenotrophomonas Maltophilia.
$40,229Megan Yasemin Nas · Northwestern University At Chicago · F31 · FY2019 · AI
D-peptide Inhibitors of Uropathogenic E. coli Adhesion Proteins to Treat Urinary Tract Infections
$40,212Marcy Robins · University Of Utah · F31 · FY2022 · AI
Task B11: Polymorph characterization and salt screening of a potential therapeutic for gram negative bacteria
$40,208Jon Mirsalis · Sri International · N01 · FY2020 · AI
AP 2. Symbiosis: Ecorationale for bacterial isolation and drug screening
$40,155Margo Genevieve Haygood · University Of Utah · U19 · FY2015 · TW
Multivariate Statistics and Machine Learning for Quality Control of Dried Ocimum Products
$40,147Evelyn Abraham · Pennsylvania State University, The · F31 · FY2023 · AT
Identification of antimicrobial specialized metabolites from the human oral microbiome to target multidrug-resistant pathogens
$40,130Susan Zelasko · University Of Wisconsin-Madison · F30 · FY2024 · AI
Inhibition of Glycoprotein Biosynthesis in Gram-Negative Pathogens
$40,125Barbara Imperiali · Massachusetts Institute Of Technology · R03 · FY2012 · MH
Task A5: Update of Generic Product Development Plan
$40,021Jon Mirsalis · Sri International · N01 · FY2021 · AI
Targeted Infection-control Program (TIP) to reduce Resistant Pathogens and Infect
$40,005Lona Mody · University Of Michigan At Ann Arbor · R01 · FY2011 · AG
Forum on Microbial Threats
$40,000Julie Liao · National Academy Of Sciences · R13 · FY2022 · FD
Forum on Microbial Threats
$40,000Julie Pavlin · National Academy Of Sciences · R13 · FY2020 · FD
Forum on Microbial Threats
$40,000Julie Liao · National Academy Of Sciences · R13 · FY2021 · FD
BIOPROSPECTING FOR MEDICINALLY IMPORTANT COMPOUNDS USING ENDOPHYTIC ORGANISMS
$39,984Jeremy Bricker · University Of Nebraska Medical Center · P20 · FY2011 · RR
Defining defensin-mediated inhibitionand enhancement of rotavirus infection
$39,910Karina Diaz-Davis · University Of Washington · F30 · FY2019 · AI
Elucidating Rgg-mediated quorum sensing networks in Streptococcus pneumoniae and their contributions in pathogenesis
$39,909Kayleigh Tovar · University Of Illinois At Chicago · F31 · FY2019 · AI
Alcohol and Pulmonary Immunity to MRSA
$39,888Sun Mi Choi · Lsu Health Sciences Center · F31 · FY2013 · AA
Task A58: Therapeutic Testing in Murine Models of Bacterial Thigh, Lung, Bacteremia and Peritonitis Infections
$39,760Lynn Miesel · Pharmacology Discovery Services Taiwan, Ltd. · N01 · FY2022 · AI
Metabolic adaptation of Citrobacter during pathogenic colonization of the gut
$39,756Kristie Miller Keeney · University Of British Columbia · F32 · FY2010 · AI
Comparison of Antimicrobial Safety and Effectiveness for the Treatment of Urinary Tract Infections During Pregnancy
$39,732Jacob Kahrs · Univ Of North Carolina Chapel Hill · F31 · FY2024 · HD
Genetic regulation of antifungal drug resistance in Candida albicans
$39,689Craig Lewis Ennis · University Of California, Merced · F31 · FY2020 · DE
The role of pyruvate oxidase in nitrosative stress resistance by Streptococcus parasanguinis
$39,571Joshua Baty · University Of Alabama At Birmingham · F31 · FY2022 · DE